| scholarly article | Q13442814 |
| P50 | author | Harold L. Moses | Q47005604 |
| Philip Owens | Q63430786 | ||
| P2093 | author name string | Anna Chytil | |
| Michael W Pickup | |||
| Sergey V Novitskiy | |||
| Dina Polosukhina | |||
| P2860 | cites work | The polarization of immune cells in the tumour environment by TGFbeta | Q37454364 |
| Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways. | Q37567229 | ||
| TGF-β Function in Immune Suppression | Q37777380 | ||
| Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function | Q37808561 | ||
| Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma | Q40907616 | ||
| Transforming growth factor-beta 1 inhibits scavenger receptor activity in THP-1 human macrophages | Q41653372 | ||
| An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice | Q42652064 | ||
| Conditional inactivation of the TGF-beta type II receptor using Cre:Lox | Q43709534 | ||
| Conditional gene targeting in macrophages and granulocytes using LysMcre mice. | Q44554898 | ||
| Cancer immunology. Cancer's bulwark against immune attack: MDS cells | Q46813671 | ||
| Cell dissociation techniques in human breast cancer--variations in tumor cell viability and DNA ploidy | Q46951481 | ||
| Progression of human bronchioloalveolar carcinoma to invasive adenocarcinoma is modeled in a transgenic mouse model of K-ras-induced lung cancer by loss of the TGF-β type II receptor. | Q51174218 | ||
| Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. | Q54462818 | ||
| TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells | Q57218941 | ||
| Deactivation of macrophages by transforming growth factor-β | Q59068031 | ||
| Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis | Q59276609 | ||
| Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. | Q64903823 | ||
| Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta | Q68251070 | ||
| Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow | Q73197413 | ||
| MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases | Q83315903 | ||
| Conditional deletion of TGF-βR1 using Langerin-Cre mice results in Langerhans cell deficiency and reduced contact hypersensitivity | Q85094762 | ||
| Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells | Q24658240 | ||
| Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 | ||
| Transforming growth factor-beta regulation of immune responses | Q28303115 | ||
| Adenosine receptors in regulation of dendritic cell differentiation and function | Q28586835 | ||
| Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis | Q28592128 | ||
| Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor | Q28593665 | ||
| Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes | Q29547633 | ||
| Subsets of myeloid-derived suppressor cells in tumor-bearing mice | Q29614297 | ||
| Macrophage diversity enhances tumor progression and metastasis | Q29615847 | ||
| Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3. | Q33916695 | ||
| TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression | Q33936542 | ||
| The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis | Q34249064 | ||
| Transforming growth factor type beta induces monocyte chemotaxis and growth factor production | Q34339289 | ||
| S100A8/A9 activate key genes and pathways in colon tumor progression | Q34802977 | ||
| Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma | Q35369888 | ||
| Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice | Q35370005 | ||
| A critical role for macrophages in promotion of urethane-induced lung carcinogenesis | Q35566757 | ||
| Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice | Q35648172 | ||
| The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity | Q35750663 | ||
| TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms | Q35814020 | ||
| Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression | Q36026081 | ||
| Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes | Q36305926 | ||
| Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta | Q36350227 | ||
| Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta | Q36362135 | ||
| Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis | Q36464443 | ||
| Myeloid-derived suppressor cells | Q36916250 | ||
| Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. | Q37118160 | ||
| Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer | Q37209259 | ||
| Transforming growth factor beta: tumor suppressor or promoter? Are host immune cells the answer? | Q37326107 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 641-651 | |
| P577 | publication date | 2012-06-08 | |
| P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
| P1476 | title | Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties | |
| P478 | volume | 92 |
| Q30574554 | Defective TGF-β signaling in bone marrow-derived cells prevents hedgehog-induced skin tumors |
| Q39027205 | Dichotomous roles of TGF-β in human cancer |
| Q33904588 | Dissecting the role of bone marrow stromal cells on bone metastases |
| Q26773228 | Distinct Functions of Neutrophil in Cancer and Its Regulation |
| Q27025321 | Dynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironment |
| Q88649847 | Early TGF-β inhibition in mice reduces the incidence of breast cancer induced bone disease in a myeloid dependent manner |
| Q49962991 | Engineering chimeric antigen receptor-T cells for cancer treatment |
| Q57200774 | Fatal demyelinating disease is induced by monocyte-derived macrophages in the absence of TGF-β signaling |
| Q90441910 | Harnessing innate immunity in cancer therapy |
| Q49842867 | Immunoregulatory functions and the therapeutic implications of GARP-TGF-β in inflammation and cancer |
| Q36398681 | Inhibition of BMP signaling suppresses metastasis in mammary cancer |
| Q50972710 | Myeloid TGF-β signaling contributes to colitis-associated tumorigenesis in mice. |
| Q38843264 | Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis. |
| Q92405284 | Neutrophils as a Therapeutic Target in Cancer |
| Q88938416 | Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses |
| Q98735502 | Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies |
| Q47119733 | Reduction in skeletal muscle fibrosis of spontaneously hypertensive rats after laceration by microRNA targeting angiotensin II receptor |
| Q28393883 | Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors |
| Q46547713 | TGF-β Signaling in Dendritic Cells Governs Colonic Homeostasis by Controlling Epithelial Differentiation and the Luminal Microbiota. |
| Q55515390 | TGF-β in T Cell Biology: Implications for Cancer Immunotherapy. |
| Q33355832 | TGF-β signaling in myeloid cells is required for tumor metastasis |
| Q39071510 | TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment |
| Q97867213 | TGFβ biology in cancer progression and immunotherapy |
| Q35023562 | TGFβ signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactions |
| Q104795035 | Targeting TGFβ signal transduction for cancer therapy |
| Q55491725 | Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade. |
| Q41811974 | The hedgehog's trick for escaping immunosurveillance: The molecular mechanisms driving myeloid-derived suppressor cell recruitment in hedgehog signaling-dependent tumors |
| Q33630845 | The roles of TGFβ in the tumour microenvironment |
| Q26996742 | Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells |
| Q60921660 | Transforming of the Tumor Microenvironment: Implications for TGF- Inhibition in the Context of Immune-Checkpoint Therapy |
| Q37739585 | p38α MAPK regulates proliferation and differentiation of osteoclast progenitors and bone remodeling in an aging-dependent manner |
Search more.